| Preface to the second edition | xi |
1 | Introduction | 1 |
1.1 | What is genetic engineering? | 1 |
1.2 | Laying the foundations | 3 |
1.3 | First steps | 4 |
1.4 | What is in store? | 6 |
Part I | The basis of genetic engineering | 9 |
2 | Introducing molecular biology | 11 |
2.1 | The flow of genetic information | 11 |
2.2 | The structure of DNA and RNA | 13 |
2.3 | Gene organisation | 16 |
2.3.1 | Gene structure in prokaryotes | 18 |
2.3.2 | Gene structure in eukaryotes | 19 |
2.4 | Gene expression | 21 |
2.5 | Genes and genomes | 23 |
2.5.1 | Genome size and complexity | 23 |
2.5.2 | Genome organisation | 24 |
3 | Working with nucleic acids | 27 |
3.1 | Isolation of DNA and RNA | 27 |
3.2 | Handling and quantification of nucleic acids | 29 |
3.3 | Radiolabelling of nucleic acids | 30 |
3.3.1 | End labelling | 30 |
3.3.2 | Nick translation | 31 |
3.3.3 | Labelling by primer extension | 31 |
3.4 | Nucleic acid hybridisation | 33 |
3.5 | Gel electrophoresis | 33 |
3.6 | DNA sequencing | 35 |
3.6.1 | Maxam--Gilbert (chemical) sequencing | 37 |
3.6.2 | Sanger--Coulson (dideoxy or enzymatic) sequencing | 37 |
3.6.3 | Electrophoresis and reading of sequences | 40 |
4 | The tools of the trade | 43 |
4.1 | Restriction enzymes--cutting DNA | 43 |
4.1.1 | Type II restriction endonucleases | 44 |
4.1.2 | Use of restriction endonucleases | 45 |
4.1.3 | Restriction mapping | 47 |
4.2 | DNA modifying enzymes | 48 |
4.2.1 | Nucleases | 48 |
4.2.2 | Polymerases | 49 |
4.2.3 | Enzymes that modify the ends of DNA molecules | 51 |
4.3 | DNA ligase--joining DNA molecules | 52 |
Part II | The methodology of gene manipulation | 55 |
5 | Host cells and vectors | 57 |
5.1 | Host cell types | 58 |
5.1.1 | Prokaryotic hosts | 58 |
5.1.2 | Eukaryotic hosts | 59 |
5.2 | Plasmid vectors for use in E. coli | 60 |
5.2.1 | What are plasmids? | 61 |
5.2.2 | Basic cloning plasmids | 61 |
5.2.3 | Slightly more exotic plasmid vectors | 63 |
5.3 | Bacteriophage vectors for use in E. coli | 66 |
5.3.1 | What are bacteriophages? | 66 |
5.3.2 | Vectors based on bacteriophage [lambda] | 70 |
5.3.3 | Vectors based on bacteriophage M13 | 74 |
5.4 | Other vectors | 75 |
5.4.1 | Hybrid plasmid/phage rectors | 76 |
5.4.2 | Vectors for use in eukaryotic cells | 77 |
5.4.3 | Artificial chromosomes | 79 |
5.5 | Getting DNA into cells | 80 |
5.5.1 | Transformation and transfection | 80 |
5.5.2 | Packaging phage DNA in vitro | 81 |
5.5.3 | Alternative DNA delivery methods | 83 |
6 | Cloning strategies | 87 |
6.1 | Which approach is best? | 87 |
6.2 | Cloning from mRNA | 89 |
6.2.1 | Synthesis of cDNA | 90 |
6.2.2 | Cloning cDNA in plasmid vectors | 93 |
6.2.3 | Cloning cDNA in bacteriophage vectors | 96 |
6.3 | Cloning from genomic DNA | 98 |
6.3.1 | Genomic libraries | 99 |
6.3.2 | Preparation of DNA fragments for cloning | 101 |
6.3.3 | Ligation, packaging and amplification of libraries | 103 |
6.4 | Advanced cloning strategies | 106 |
6.4.1 | Synthesis and cloning of cDNA | 106 |
6.4.2 | Expression of cloned cDNA molecules | 109 |
6.4.3 | Cloning large DNA fragments in BAC and YAC vectors | 111 |
7 | The polymerase chain reaction | 115 |
7.1 | The (short) history of the PCR | 115 |
7.2 | The methodology of the PCR | 118 |
7.2.1 | The essential features of the PCR | 118 |
7.2.2 | The design of primers for PCR | 121 |
7.2.3 | DNA polymerases for PCR | 121 |
7.3 | More exotic PCR techniques | 123 |
7.3.1 | PCR using mRNA templates | 123 |
7.3.2 | Nested PCR | 124 |
7.3.3 | Inverse PCR | 126 |
7.3.4 | RAPD and several other acronyms | 127 |
7.4 | Processing of PCR products | 129 |
7.5 | Applications of the PCR | 130 |
8 | Selection, screening and analysis of recombinants | 132 |
8.1 | Genetic selection and screening methods | 133 |
8.1.1 | The use of chromogenic substrates | 133 |
8.1.2 | Insertional inactivation | 135 |
8.1.3 | Complementation of defined mutations | 136 |
8.1.4 | Other genetic selection methods | 137 |
8.2 | Screening using nucleic acid hybridisation | 138 |
8.2.1 | Nucleic acid probes | 138 |
8.2.2 | Screening clone banks | 139 |
8.3 | Immunological screening for expressed genes | 141 |
8.4 | Analysis of cloned genes | 143 |
8.4.1 | Characterisation based on mRNA translation in vitro | 143 |
8.4.2 | Restriction mapping | 145 |
8.4.3 | Blotting techniques | 145 |
8.4.4 | DNA sequencing | 148 |
Part III | Genetic engineering in action | 151 |
9 | Understanding genes and genomes | 153 |
9.1 | Analysis of gene structure and function | 153 |
9.1.1 | A closer look at sequences | 154 |
9.1.2 | Finding important regions of genes | 155 |
9.1.3 | Investigating gene expression | 157 |
9.2 | From genes to genomes | 159 |
9.2.1 | Analysing genomes | 160 |
9.2.2 | Mapping genomes | 161 |
9.3 | Genome sequencing | 165 |
9.3.1 | Sequencing technology | 165 |
9.3.2 | Genome projects | 165 |
9.4 | The human genome project | 167 |
9.4.1 | Whose genome, and how many genes does it contain? | 169 |
9.4.2 | Genetic and physical maps of the human genome | 170 |
9.4.3 | Deriving and assembling the sequence | 174 |
9.4.4 | What next? | 175 |
10 | Genetic engineering and biotechnology | 178 |
10.1 | Making proteins | 179 |
10.1.1 | Native and fusion proteins | 179 |
10.1.2 | Yeast expression systems | 181 |
10.1.3 | The baculovirus expression system | 182 |
10.1.4 | Mammalian cell lines | 183 |
10.2 | Protein engineering | 183 |
10.3 | Examples of biotechnological applications of rDNA technology | 185 |
10.3.1 | Production of enzymes | 185 |
10.3.2 | The BST story | 187 |
10.3.3 | Therapeutic products for use in human health-care | 190 |
11 | Medical and forensic applications of gene manipulation | 197 |
11.1 | Diagnosis and characterisation of medical conditions | 197 |
11.1.1 | Diagnosis of infection | 198 |
11.1.2 | Patterns of inheritance | 198 |
11.1.3 | Genetically based disease conditions | 201 |
11.2 | Treatment using rDNA technology--gene therapy | 210 |
11.2.1 | Getting transgenes into patients | 211 |
11.2.2 | Gene therapy for adenosine deaminase deficiency | 214 |
11.2.3 | Gene therapy for cystic fibrosis | 214 |
11.3 | DNA profiling | 215 |
11.3.1 | The history of 'genetic fingerprinting' | 216 |
11.3.2 | DNA profiling and the law | 218 |
11.3.3 | Mysteries of the past revealed by genetic detectives | 219 |
12 | Transgenic plants and animals | 224 |
12.1 | Transgenic plants | 224 |
12.1.1 | Why transgenic plants? | 225 |
12.1.2 | Ti plasmids as vectors for plant cells | 226 |
12.1.3 | Making transgenic plants | 228 |
12.1.4 | Putting the technology to work | 230 |
12.2 | Transgenic animals | 237 |
12.2.1 | Why transgenic animals? | 237 |
12.2.2 | Producing transgenic animals | 238 |
12.2.3 | Applications of transgenic animal technology | 241 |
13 | The other sort of cloning | 247 |
13.1 | Early thoughts and experiments | 247 |
13.1.1 | First steps towards cloning | 249 |
13.1.2 | Nuclear totipotency | 250 |
13.2 | Frogs and toads and carrots | 250 |
13.3 | A famous sheep--the breakthrough achieved | 253 |
13.4 | Beyond Dolly | 256 |
14 | Brave new world or genetic nightmare? | 259 |
14.1 | Is science ethically and morally neutral? | 259 |
14.2 | Elements of the ethics debate | 260 |
14.1 | Does Frankenstein's monster live inside Pandora's box? | 262 |
| Suggestions for further reading | 263 |
| Using the World Wide Web | 266 |
| Glossary | 270 |
| Index | 287 |